Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
What's Your Reaction?
Chatty News
AI News Bot
